JB Chemicals & Pharmaceuticals Ltd.
Snapshot View

2042.00 -27.90 ▼-1.4%

25 November 2022, 04:01:00 PM
Volume: 2,922

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jbpharma.com
Market Cap 15,876.56 Cr.
Enterprise Value(EV) 16,135.93 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 49.75 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 41.04 Trailing Twelve Months Ending 2022-09
Industry PE 35.02 Trailing Twelve Months Ending 2022-09
Book Value / Share 299.31 Trailing Twelve Months Ending 2022-09
Price to Book Value 6.82 Calculated using Price: 2,042.00
Dividend Yield 0.80 Period Ending 2022-03
No. of Shares Subscribed 7.74 Cr. 77,354,187 Shares
FaceValue 2
Company Profile
J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs. JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules. In India and International markets, JBCPL is also known as Unique Pharmaceutical Laboratories and is a division of JBCPL.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.35%
1 Week
-3.52%
1 Month
+6.62%
3 Month
+13.55%
6 Month
+30.15%
1 Year
+26.07%
2 Year
+114.17%
5 Year
+605.72%
10 Year
+2449.31%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.99 9.86 14.80 14.48 9.89 13.28 18.69 27.64 19.89
Return on Capital Employed (%) 8.50 13.49 17.72 16.87 13.70 19.59 23.71 36.53 25.48
Return on Assets (%) 4.64 7.08 9.21 8.99 6.43 8.52 12.53 19.55 13.69

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1,043 995 1,184 1,364 1,442 1,480 1,435 1,810 2,134 2,315
Non Curr. Liab. 32 33 31 27 46 65 63 72 79 327
Curr. Liab. 276 460 797 693 737 782 516 687 852 556
Minority Int. 2 2 3 3 3 4 4
Equity & Liab. 1,351 1,487 2,014 2,086 2,226 2,329 2,017 2,572 3,069 3,198
Non Curr. Assets 370 586 832 879 718 741 741 679 1,326 1,658
Curr. Assets 981 901 1,182 1,207 1,509 1,589 1,276 1,894 1,743 1,541
Misc. Exp. not W/O
Total Assets 1,351 1,487 2,014 2,086 2,226 2,329 2,017 2,572 3,069 3,198

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 1,022 1,144 1,232 1,368 1,414 1,643 1,775 2,043 2,424 2,819
Other Income 38 11 57 54 55 41 51 117 40 9
Total Income 1,060 1,155 1,288 1,422 1,469 1,685 1,826 2,159 2,464 2,828
Total Expenditure -874 -964 -1,026 -1,140 -1,215 -1,337 -1,397 -1,486 -1,882 -2,209
PBIDT 186 191 263 283 254 347 428 673 583 619
Interest -6 -7 -11 -5 -3 -5 -3 -7 -5 -17
Depreciation -28 -39 -41 -47 -57 -56 -66 -69 -73 -93
Taxation -26 -45 -50 -46 -55 -93 -77 -148 -119 -124
Exceptional Items -65 -10
PAT 62 100 161 184 139 194 272 449 386 385
Minority Interest 0 0 0 -1 0 -1 -1 -1
Share Associate 1
Other Related Items
Consolidated Net Profit 62 100 163 184 138 193 272 448 385 385
Adjusted EPS 7 12 19 22 17 24 35 58 50 50

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 84 -14 127 140 201 123 194 276 315 170
Cash Fr. Inv. -116 -143 -112 -28 -45 -21 -28 24 -231 2
Cash Fr. Finan. -31 12 -1 -100 -184 -60 -156 -306 -87 -138
Net Change -63 -144 13 13 -28 43 11 -6 -3 34
Cash & Cash Eqvt 156 12 25 9 -21 21 32 26 22 57

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 55.91 55.91 55.91 55.91 55.91 54.00 54.00 54.00 53.96
Public 44.09 44.09 44.09 44.09 44.09 46.00 46.00 46.00 46.04
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 18 Nov 2022
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Enclosed please find Transcript of Conference Call which was scheduled for Investors and Analysts on November 14 2022 at 3.30 p.m. IST in relation to results and developments for the second quarter ended on September 30 2022.
Thu, 17 Nov 2022
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Compensation Committee of the Board of Directors of the Company has on November 17 2022 allotted 18 730 fully paid up equity shares of Rs. 2/- each of the Company to certain employees on exercise of stock options granted to them pursuant to JBCPL Employee Stock Option Scheme 2021.
Mon, 14 Nov 2022
Audio Recording Of Investors/Analysts Call With Management
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 - Audio recording of Investors/analysts call with Management

Technical Scans View Details >>

Fri, 25 Nov 2022
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months
High Increase 2 Years High Increase 2 Years

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On JB Chemicals & Pharmaceuticals Ltd.

What is JB Chem & Pharma share price?

Can I buy JB Chem & Pharma shares now?

What is the Dividend Yield of JB Chem & Pharma?

What is the Market Cap of JB Chem & Pharma?

What are the key metrics to analyse JB Chem & Pharma?

What is the 52 Week High and Low of JB Chem & Pharma?

What is the trend of JB Chem & Pharma share price?